Highlights. (i) Malaria, peroxisome proliferator-activated receptor (PPAR) signaling, and the adipocytokine signaling pathway are key pathways in oxaliplatin-resistant colorectal cancer- (CRC-) targeted therapy. Here, PPARA is linked to colorectal carcinoma.